ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,4,Paracentesis,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1,6,Thoracic cavity drainage,Chest wall and mediastinal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
2,1,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
3,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
4,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5,2,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
5,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
7,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
8,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
8,2,Heart valve operation,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
8,3,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
8,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
8,5,Postoperative renal failure,Urinary tract procedural complications,Procedural related injuries and complications NEC,Inj&P,N
9,1,5-hydroxyindolacetic acid,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
10,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
